ArticleInternational journal of clinical oncology2024

Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan.

Kenji Hiraizumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.